-
A rule taking effect Jan. 1 was intended to stop one set of abuses by pharmacy benefit managers, but some pharmacists say it’s enabling these price brokers to simply do new things unfairly.
-
The nationwide walkout is slated to continue through Wednesday. It's the latest attempt by pharmacists to pressure chains to address concerns about staffing they say lead to burnout and mistakes.
-
The company said that customers in College Station, Texas, can now get prescriptions delivered by a drone within an hour of placing their order.
-
Rite Aid’s plan to close more stores as part of its bankruptcy process raises concern about how that might hurt access to medicine and care.
-
It will likely take a few weeks before medical marijuana is available in pharmacies. After they submit applications, inspections will be required before approval is granted.
-
Drug and staffing shortages remain, and stores are dealing with a new vaccine and insurance coverage for COVID shots. Some have addressed challenges, but customers can expert slower service and lines.
-
Thousands of patients with autoimmune diseases who rely on Humira, with a list price of $6,600 a month, could get financial relief from new low-cost rivals. So far, the pharmacy benefit managers that control drug prices have not delivered on those savings.
-
To drive down costs, insurers are delivering high-priced infusion drugs via third-party pharmacies. Hospitals and clinics are trying to convince states to limit this practice, known as "white bagging."
-
Drug shortages continue as Florida health care experts navigate what some expect to be the new normal of pharmacy.
-
Drug-makers, pharmacies, and physicians blame pharmacy benefit managers for high drug prices. Florida has already taken action. Now, Congress is finally on board, too, but will it matter?